Ingevity (NGVT) Stock Forecast & Price Target
$2.56B
Market Cap
45.22
P/E
13.91
Forward P/E
—
Score
NGVT price $74.44 +0.28 +0.37%
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| 908300000 | 972400000 | 1133600000 | 1292900000 | 1216100000 | 1391500000 | 1668300000 | 1692100000 | 1406400000 | 1167600000 |
Ingevity Corporation (NGVT) is a global provider specializing in the production and distribution of advanced chemical solutions and activated carbon products. The company's reach extends across North America, the Asia Pacific region, Europe, the Middle East, Africa, and South America. Its business operations are organized into two principal divisions: Performance Materials and Performance Chemicals. The Performance…
Consensus Buy from 13 analysts. Average price target $71.50, -4.0% versus the current price. Low $56.00. High $83.00.
Insights · Dividends · Forecast · Financials · Learn
Analysts have an average 12-month price target of $71.50 for Ingevity (NGVT), 4.9% below the current price of $75.19. Of 13 analysts covering the stock, 10 rate it Buy or Strong Buy, 3 Hold, and 0 Sell or Strong Sell, giving a consensus of Buy.
Forecasts are third-party estimates and often wrong. They are not investment advice.
| Low | $56.00 |
|---|---|
| Average | $71.50 |
| High | $83.00 |
The average is 4.9% below the current price of $75.19.
Of 13 analysts, 10 rate Ingevity Buy or Strong Buy, 3 Hold, and 0 Sell or Strong Sell. The consensus label is Buy. That split is not a recommendation.
Analyst averages on file: 2026, EPS $5.35, revenue $1.11 billion. 2027, EPS $6.04, revenue $1.13 billion.
The Stocklytics Score, when it is published for NGVT, averages value, quality, and growth on a 0–100 scale. It is not a price target. Fair value is a separate estimate on the fair value tab.
$71.50 average, with a published range of $56.00 to $83.00.
The consensus is Buy from 13 analysts. This is not a recommendation.
Analysts' average EPS estimate for 2026 on file is $5.35. The average revenue estimate is $1.11 billion.
No reliable forecast exists that far out.
The next earnings date is shown on the stock page when a future report is on the calendar. This forecast does not invent a date.
Related: Ingevity · Financials · Dividends · Compare · AI stocks
Capital is at risk. Stocklytics is operated by Stocklytics Inc., a Marshall Islands company. It is not regulated by the FCA and does not give investment advice.
$2.56B
Market Cap
45.22
P/E
13.91
Forward P/E
—
Score